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ABSTRACT Atopic dermatitis is a multifactorial allergic skin disease in humans and dogs. Genetic pre-
disposition, immunologic hyperreactivity, a defective skin barrier, and environmental factors play a role
in its pathogenesis. The aim of this study was to analyze gene expression in the skin of dogs sensitized to
house dust mite antigens. Skin biopsy samples were collected from six sensitized and six nonsensitized
Beagle dogs before and 6 hr and 24 hr after challenge using skin patches with allergen or saline as
a negative control. Transcriptome analysis was performed by the use of DNA microarrays and expression of
selected genes was validated by quantitative real-time RT-PCR. Expression data were compared between
groups (unpaired design). After 24 hr, 597 differentially expressed genes were detected, 361 with higher
and 226 with lower mRNA concentrations in allergen-treated skin of sensitized dogs compared with their
saline-treated skin and compared with the control specimens. Functional annotation clustering and
pathway- and co-citation analysis showed that the genes with increased expression were involved in
inflammation, wound healing, and immune response. In contrast, genes with decreased expression in
sensitized dogs were associated with differentiation and barrier function of the skin. Because the sensitized
dogs did not show differences in the untreated skin compared with controls, inflammation after allergen
patch test probably led to a decrease in the expression of genes important for barrier formation. Our results
further confirm the similar pathophysiology of human and canine atopic dermatitis and revealed genes







Atopic dermatitis (AD) is a chronic inflammatory skin disease with an
increasing prevalence in both humans and dogs in industrialized
countries (Leung 1999; Hillier and Griffin 2001). It manifests as
a recurrent, pruritic dermatitis, in most cases with allergen-specific
serum-IgE (Wüthrich 1978; Lian and Halliwell 1998; Olivry et al.
2001; Halliwell 2006), and is often complicated by secondary skin
infections (Leyden et al. 1974; Deboer and Marsella 2001). Diag-
nosis of canine AD (cAD) is based on history, clinical signs, and
the exclusion of other causes of pruritus (Deboer and Hillier 2001).
Spontaneous remission of cAD is rare and therapy can be unsatisfying
(Olivry and Sousa 2001; Olivry et al. 2010). Allergen-specific immuno-
therapy, the only specific treatment for the disease, is a long-term
therapy and is not efficacious in all patients (Olivry et al. 2010). In
many patients, lifelong symptomatic therapy is needed.
The pathophysiology of cAD is still not fully elucidated. A complex
interaction between environmental and genetic factors seems to
affect skin barrier function and the immunologic response of
patients in both human and canine AD (Marsella et al. 2011). In
linkage analyses and candidate gene studies, associations to and
polymorphisms in different epidermal and immunologic genes were
identified in AD (Cookson and Moffatt 2002; Barnes 2010; Boguniewicz
and Leung 2011; Bussmann et al. 2011). A few years ago a central role
of the barrier abnormality in atopic skin was proposed for AD
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(the outside–inside view of disease pathogenesis) (Taieb 1999; Elias and
Feingold 2001). In human AD, a defective skin barrier is hypothe-
sized to facilitate the penetration of allergens into the skin, which
leads to sensitization against environmental allergens and subse-
quent cutaneous inflammation, which further aggravates skin barrier
impairment. The release of the canine genome sequence in 2005
(Lindblad-Toh et al. 2005) permitted functional genome analysis
and the analyses of gene expression patterns in the dog. With micro-
array technology, expression of thousands of genes can be evaluated
simultaneously to identify differentially expressed genes (DEG) as
candidate genes for further studies (Schulze and Downward 2001).
The aim of this study was to compare the gene expression pattern
before and after challenge with an allergen patch test in the skin of
house dust mite–sensitized dogs compared with nonsensitized con-
trols in a highly standardized manner to identify new genes possibly
involved in the pathophysiology of AD.
MATERIALS AND METHODS
Microarray (MA) technique is a sensitive method for the measurement
of gene expression. To avoid data corruption and/or misinterpretation
due to environmental conditions or aberrant/differing age of skin
lesions, conditions for the biological model, specimen collection, and
preparation were highly standardized.
Animals and specimen collection
A total of 12 Beagle dogs owned by the Novartis Centre de Recherche
Sante Animale (Saint-Aubin FR, Switzerland) were included in the
study. Six of these dogs were previously sensitized to Dermatophagoides
farinae (D.f.) (four males and two females) and six were nonallergic
control dogs (two males and four females). The former dogs had been
sensitized epicutaneously once weekly for 8 wk to the house dust mite
Dermatophagoides farinae (powder of milled dust mite, 99% pure
Dermatophagoides farinae, mixed with saline to a pasty consistency;
Greer Laboratories, North Carolina). Successful sensitization was
confirmed with two challenges using a D.f. slurry; all dogs had to
develop skin lesions over a predefined score. Subsequent studies
showed that they also had serum D.f.-specific IgE and positive intradermal
tests for D.f. The age of the dogs ranged from 2 to 3 yr (mean, 2.3 yr).
Environmental and feeding conditions were the same for all dogs.
This study was approved by the appropriate regulatory office.
A 10- · 10-cm area on the lateral chest of each dog was shaved
with a clipper blade (Favorita II GT 104; Aesculap AG, Germany).
Four days later, a patch test (PT) was conducted with 75 mg of HDM
paste (powder of milled dust mite, 99% pure Dermatophagoides
farinae, mixed with saline to a pasty consistency; Greer Laboratories,
North Carolina) and 50 ml of physiologic saline as a negative control.
The patch test sites were bandaged carefully to prevent trauma or
movement of the patches. In addition, each dog wore a mesh body
suit. The allergen patch test was carefully relocated in the exact same
position and bandages were replaced at the 6 hr intervention. In total,
five 8-mm punch biopsies were performed in each dog using local
anesthesia; each site used 0.5 ml of 2% lidocaine (Vetoquinol AG,
Ittingen, Switzerland). One specimen was obtained before (0 hr) patch
test and two biopsy specimens were obtained at 6 hr and at 24 hr
(6 hr, 24 hr) after patch test with both allergen (A) and saline (S)
applications (Supporting Information, Table S1 in File S1). After clip-
ping and at each time point (0 hr, 6 hr, 24 hr) before collecting the
biopsy samples, skin was evaluated for signs of inflammation. To in-
vestigate the cellular response and gene expression in the skin, biopsy
specimens were cut into three pieces with two parallel cuts. The
middle part of each specimen was placed in 10% neutrally buffered
formalin. The other two pieces were placed into RNAlater (Qiagen
GmbH, Hilden, Germany) and after 4 d of storage at 4, these speci-
mens were stored at 220 until further processing.
Histological evaluation
For quantitative histological analysis, formalin-fixed specimens were
embedded in paraffin and routinely stained with hematoxylin and
eosin (HE). Specimens were stained by the Institute of Veterinary
Pathology in Munich. Sections were then photographed (ColorView
III; Olympus Soft Imaging Solutions GmbH) and round cells were
counted (cells/mm2) with analySIS FIVE Software (Soft Imaging Sys-
tem; Olympus).
Microarray analysis
Total RNA was isolated from the skin specimen using Trizol reagent
(Life Technologies GmbH, Darmstadt, Germany) according to the
manufacturer’s instructions. The quantity and purity of RNA were
measured with a NanoDrop 1000 (Peqlab Biotechnologie GmbH,
Erlangen, Germany). The quality of total RNA was determined
electrophoretically with an Agilent 2100 Bioanalyzer (RNA 6000
Nano Kit, 5067-1511; Agilent Technologies, Waldbronn, Germany).
Transcriptome analysis was performed with an Agilent 8x60K Canine
Custom Gene Expression Array. The canine custom array was
designed using the Agilent webtool "eArray." Relevant genes based
on previous studies of human and canine AD were included in the
array design. Cy3-labeled cRNA was produced with the low-input
Quick Amp Labeling Kit one color (Agilent Technologies) and after
fragmentation hybridized to the MAs according the manufacturer’s
instructions. Hybridized and washed slides were scanned at 2-mm
resolution with a DNA Microarray Scanner G2505C (Agilent Tech-
nologies). Image processing was performed with Feature Extraction
Software 10.7.3.1 (Agilent Technologies). Processed signals were fil-
tered based on "is well above background" flags (detection in at least
five of six samples in at least one group). Thereafter, expression data
were normalized using the Bioconductor package "vsn" (Huber et al.
2002) in "R" (version 2.12.2; http://www.r-project.org/). For quality
control, microarray data were analyzed with box plots before and after
normalization and a heatmap based on pair-wise distances. Signifi-
cance analysis was performed with the package "limma" (version
3.6.9) (Smyth 2005). Significance thresholds were set at a false discovery
rate (FDR) of 5% and fold change (FC) of at least 1.5-fold.
To characterize gene expression responses in the skin of sensitized
dogs after allergen PT, an unpaired two-class analysis was performed
for the 0-hr biopsy specimens to find general differences in gene
expression between sensitized and nonallergic dogs in untreated skin.
Furthermore, an unpaired multifactorial analysis was performed for
the 6 hr and the 24 hr specimens comparing the differences of allergen
with saline application between allergic and control dogs.
The array annotation was complemented based on Ensembl,
Entrez Gene, and BLAST analyses to obtain canine and human
(putative orthologous) gene IDs. After statistical analysis, the values of
genes represented by more than one microarray probe were sum-
marized using the "Group" tool implemented in the Galaxy software
(http://galaxy.psu.edu/).
Functional analysis of microarray data
Multi Experiment Viewer Software (version 4.7.1; http://www.tm4.
org/) (Saeed et al. 2003) was used for hierarchical cluster (HCL)
and self-organizing tree algorithm (SOTA) analysis. For these analy-
ses, the log2 transformed mean expression value of each group was
subtracted from the mean expression value of all groups. Functional
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classification of differentially expressed genes (DEG) was conducted
using the "functional annotation clustering" and the "functional an-
notation chart" tools of the Database of Annotation, Visualization,
and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/
home.jsp) (Huang et al. 2008), the Kegg Mapper Pathway analysis
tool of the Kyoto Encyclopedia of Genes and Genomes (KEGG) database
(http://www.genome.jp/kegg/tool/map_pathway1.html) (Kanehisa et al.
2008), and the keyword enrichment tool CoPub (http://services.nbic.nl/
copub5) (Frijters et al. 2008). Analyses were performed based on
Entrez Gene IDs of the putative human orthologous genes.
Quantitative real-time RT-PCR
The results of the MA analysis were verified by validating the ex-
pression of selected DEG by quantitative real-time RT-PCR (qPCR).
Specific primers were designed using the NCBI Primer-BLAST tool
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) and synthesized by
Thermo Fisher Scientific GmbH (http://www.thermoscientific.com/
biopolymers; Germany). The sequences of the used qRT-PCR-Primer
are shown in Table S2. The same RNA samples were used for qPCR
and MA analysis. First-strand cDNA was synthesized starting from
1 mg of total RNA with the Sprint RT Complete-Double PrePrimed
48-well strips Kit (Takara Bio Europe/Clontech, Saint-Germain-en-Laye,
France) according to the manufacturer’s instructions. A two-step qPCR
experiment was performed (PMID 22031715) (Streyl et al. 2012).
The Power SYBR Green PCR Master Mix and RT-PCR (Applied
Biosystems, Darmstadt, Germany) was applied in the thermal cycler
(StepOne Real-Time PCR System; Applied Biosystems) and evaluated
with the qPCR StepOne Software (V 2.2.2; Applied Biosystems. The
cycle thresholds (CTs) determined for the target genes were normal-
ized against the geometric mean of the reference genes RLPL13A,
LOC479750 (CCZ1) as described by Wood et al. (2008) and UBB to
obtain ΔCT values. Quantitative PCR results were statistically evalu-
ated with the same parameters as microarray data in limma.
RESULTS
Clinical evaluation of patch test sites
The skin of all dogs showed no abnormal dermatologic findings after
clipping and at the 0-hr and 6 hr time points for both allergen (n = 6)
and saline-treated skin (n = 6). The skin of the control group was also
unremarkable after 24 hr. At that time, three of the six sensitized dogs
showed mild erythema at the allergen (A) site but no visible reactions
at the control (S) site.
Round cell counts
Analysis of round cell counts showed increasing round cell numbers
in the skin of sensitized dogs treated with allergen (Figure 1). How-
ever, the difference was not statistically significant when comparing
the skin specimens for all time points and treatments (0 hr, 6 hr saline,
6 hr allergen, 24 hr saline, 24 hr allergen) (Kruskal Wallis test, P = 0.49
and P = 0.08 in nonsensitized and sensitized dogs, respectively).
Microarray results
RNA integrity number values (RIN) of the 60 isolated total RNA
samples ranged from 7.0 to 8.6, except for one sample (no. 14) that
had RIN of 3.3. DNA microarrays representing more than 22,000
unique canine genes were used to compare the global gene expression
profiles. After data processing and normalization, the quality control
(box plots and pairwise distance heatmap) of the data set revealed
lower total signal intensity and poor correlation to all other samples
for sample 14 (sensitized dog 24 hr after allergen application). Based
on this result and the poor integrity of this sample, the corresponding
data set was excluded from further analysis.
Statistical analysis was performed to identify differential gene
expression after treatment with allergen and saline control between
sensitized and nonsensitized control dogs (Table 1). No significant
expression differences were found before treatment (0 hr) between
sensitized and healthy control dogs. The unpaired multifactorial anal-
ysis of the 6 hr time point showed only nine differentially expressed
genes (DEG). Of these, only five could be assigned to hitherto known
genes (Table 2). The unpaired multifactorial analysis of the skin bi-
opsy specimens 24 hr after treatment revealed 587 DEG; 361 were
upregulated and 226 were downregulated in the skin of sensitized dogs
(Table 3). The complete list of DEG between sensitized and nonsensitized
dogs 24 hr after patch test with allergen and saline is provided in the
File S2.
Bioinformatics analysis of DEG 24 hr after PT
To visualize gene expression changes between treatments and sen-
sitized compared with control dogs, hierarchical cluster analysis
(HCL) and clustering of similar expression profiles over time [self-
organizing tree algorithm (SOTA) analysis] were performed based on
expression values relative to the mean expression value of all samples
for each gene, respectively. The input for the SOTA analysis was:
Metric: Pearson correlation, max. cycles: 3, with default parameters
[mean-centered log2-transformed normalized expression values (vsn
value 2 mean of vsn values of all samples)]. HCL analysis was per-
formed with the DEG of the 24 hr unpaired multifactorial analysis to
group these genes based on similarity in expression across the treat-
ment groups and to cluster the groups on the basis of similarities in
gene expression pattern (Figure 2). Basically, this analysis revealed two
major gene sets. Each gene set was then used to extract functional
gene sets by “functional annotation clustering” and “functional anno-
tation chart” analyses with DAVID. DAVID analysis of gene set 1,
which contained genes with increased expression in sensitized dogs,
revealed genes related to "immune response" and "inflammatory re-
sponse" (Table 3). In contrast, genes belonging to gene set 2 (decreased
in sensitized dogs) were known to be involved in epidermal develop-
ment and skin barrier formation (Table 3). Detailed results of DAVID
Figure 1 Round cell counts in skin biopsy specimens from patch test
sites of allergic and normal dogs before and 6 hr and 24 hr after
application of allergen and negative control (saline). A_A = skin of
allergic dogs after allergen patch test; A_S = skin of allergic dogs after
saline patch test; NA_A = skin of nonallergic dogs after allergen patch
test; NA_S = skin of nonallergic dogs after saline patch test.
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analyses of gene set 1 and gene set 2 and the used gene lists are pro-
vided in File S3.
To determine if there were gene sets with a similar expression profile
over time, SOTA analysis was performed and genes were assigned to
four clusters (Figure 3). Genes of the first cluster showed increased
expression in both sensitized and nonsensitized dogs after saline and
allergen treatment. The allergen-treated skin of sensitized dogs showed
the greatest increase. There was no further increase between the 6 hr
and the 24 hr time points in the allergen-treated skin of nonsensitized
dogs. Genes of cluster 1 were associated with functional categories such
as "immune response," "inflammatory response," and "response to in-
jury." Genes of the second cluster showed a reverse expression profile to
the first cluster with decreasing expression over time. The strongest
decrease was seen in the allergen-treated skin of sensitized dogs. There
was no further decrease, but rather an increase between 6 hr and 24 hr
in allergen-treated skin of nonsensitized dogs. For the genes of cluster 2,
the functional terms "epidermis development," "epidermal differentia-
tion," and "keratinocyte differentiation" showed the highest enrichment
scores. Prima facie cluster 3 and cluster 4 showed equal expression
behavior. In both gene clusters, the expression in the skin of allergen-
treated sensitized dogs decreased between 6 hr and 24 hr. The expres-
sion in the other groups increased to that of the 6 hr biopsy and then
also decreased to that of the 24 hr time point, with one exception in
cluster 3, where the expression increased between the 6 hr and 24 hr
time points in the skin of allergen-treated nonsensitized dogs. Cluster 3
and cluster 4 contained both genes related to cell junctions. Details of
the DAVID results for the SOTA clusters are shown in File S4.
DEG were further categorized and genes of interest were selected
based on a literature review and the literature proposed by CoPub
(Table 4).
Validation of microarray results by quantitative real-
time RT-PCR
To validate MA results, 18 of these genes were selected for quantitative
PCR (qPCR). Results were analyzed with limma similar to the MA
data. Overall, expression differences identified by MA analysis were
confirmed (Table 5). For some of the analyzed genes, p-values were
not significant (p.0.05) because of variations in expression differ-
ences between dogs.
DISCUSSION
This study evaluated the cutaneous gene expression of six normal and
six house dust mite–sensitized dogs under controlled environmental
conditions using patch tests. Two patches were applied to each dog,
one with the allergen (D.f.) and the other with saline. Biopsy speci-
mens were collected before and at 6 hr and 24 hr after patch appli-
cation. We identified 587 differentially expressed genes between
sensitized and normal control dogs. In our setting, variables such as
breed, age, chronicity, and living conditions were standardized. In
previous studies, dogs with naturally occurring disease were evaluated
(Merryman-Simpson et al. 2008; Wood et al. 2009) and their variation
in the above listed factors made it more difficult to identify subgroups
of genes deregulated in AD. As expected, no dog showed dermatologic
changes after saline treatment, similar to the findings of Marsella et al.
(2006). The clinical change detected after 24 hr is in agreement with
our histological findings, in which the influx of inflammatory cells was
limited to the allergen-treated skin of the sensitized dogs.
Microarray analysis of skin biopsy samples collected before the
patch test (0 hr) did not reveal any DEG. This supports the hypothesis
that artificially sensitized dogs should not suffer from a genetically
determined defective skin barrier and corresponding gene expression
changes. Furthermore, these results suggest that sensitization does not
induce a permanent expression change of genes involved in inflam-
mation, but rather an ability for disturbed reactivity on re-exposure to
allergen.
Unexpectedly, the multifactorial analysis of the 6 hr biopsy spec-
imens revealed only nine DEG, and of these genes only five were
sufficiently annotated. Because only a few genes were upregulated or
downregulated even before the adjustment, it seems likely that the
short time period did not permit changes of sufficient magnitude to
n Table 1 Statistical analysis and differentially expressed genes in allergic and nonallergic dogs after patch
testing with allergen and saline
Comparison Groups Included and Calculation Up Down
Two-class unpaired, 0 hr A0hr-N0hr 0 0
Unpaired multifactorial, 6 hr (A.a0.6hr-A.s0.6hr)-(N.a.6hr-N.s.6hr) 6 3
Unpaired multifactorial, 24 hr (A.a.24hr-A.s.24hr)-(N.a.24hr-N.s.24hr) 361 226
A, allergic; a, allergen; s, saline; N, nonallergic.






















482051 ZFAT ENSCAFT00000001794 XM_843165 ENSCAFT00000001794 482051 ZFAT 20.651 0.0003 0.999
— — CO597689 CO597689 — — 20.725 0.0006 0.999
— — BI421087 — — 20.809 0.0009 0.999
— — TC78107 — — 0.972 0.0009 0.999
403981 CCL2 NM_001003297 NM_001003297 NM_001003297 — — 1.973 0.0015 0.999
448792 CCL8 NM_001005255 NM_001005255 NM_001005255 448792 CCL8 1.953 0.0017 0.999
— — — — 0.632 0.0006 0.999
485412 DBX1 XM_542531 485412 LOC486388 0.697 0.0002 0.999
490156 GFI1 NM_001012719 NM_001012719 NM_001012719 490156 GFI1 0.827 0.0008 0.999
Cfa, Canis lupus familiaris; Hsa, Homo sapiens; Coeff., log2 fold change.
a
p-value = nominal p-value.
b
p-value adj. = p-value corrected for multiple testing.
1790 | P. Schamber et al.
reach statistical significance. The inflammatory chemokine (C-C motif)
ligands (CCL) 2 and 8 showed the highest gene expression changes.
In contrast, the 24 hr specimen analysis showed 587 DEG. Val-
idation of 18 selected genes by qPCR showed good agreement with the
microarray data for these genes. Subsequent bioinformatics analysis
of DEG 24 hr after PT assigned these genes to functional groups that
are important for skin barrier formation and for an inflammatory
response.
In contrast to normal dogs, genes related to inflammation, immune
response, and response to injury increased in the skin of sensitized
dogs. This was observed to a lesser degree in the control saline patch
test area and more prominently with allergen PT. These results could
be due to the resultant systemic effects of local allergen exposure, as
presumed in human AD (Togias 2004). Most of the genes of the SOTA
clusters 2–4 belonging to functional groups important for the skin
barrier (epidermal differentiation and cell junctions) showed a reverse
expression profile to genes of cluster 1 with a trend to decreased
expression. Sensitized dogs again had the strongest changes within
the allergen-treated skin. In 2009 Elias and Schmuth postulated their
new “outside-inside-outside” hypothesis referring to the pathogenesis
of human AD (Elias and Schmuth 2009). They proposed that inherited
skin barrier defects lead to increased penetration of allergens and that
the subsequent inflammation further aggravates the skin barrier dis-
ruption by disturbing the protein synthesis in the stratum corneum. In
our dogs, the skin barrier defects seem to be a result of inflammation
rather than a preexisting genetic defect, which seems logical in these
artificially sensitized dogs, and corresponds to a subset of human
patients in which an immunologic defect is responsible for develop-
ment of atopic disease (Oh et al. 2009; Trzeciak et al. 2010; Minegishi
and Saito 2011). The expression of skin barrier genes in nonsensitized
dogs slightly increased between 6 hr and 24 hr. This may be due to
regulatory mechanisms that strengthen the skin barrier after an insult.
DEG related to inflammation
The search for quantitatively enriched functional terms (DAVID) and
biological key words (CoPub) associated with the 24 hr DEG revealed
the highly enriched functional terms related to inflammation. The
immunopathogenesis of AD is characterized by different Th-cell
subsets and cytokine profiles. In both atopic dogs and humans, the
acute inflammation is characterized by increased T-helper (Th) 2 cells
and their cytokines (Leung 1999; Nuttall et al. 2002). In chronic in-
flammation, an increased Th1 response has also been noted in dogs
(Nuttall et al. 2002).
The genes related to inflammation that were upregulated in
sensitized dogs after allergen challenge were chemokines, cytokines,
their ligands, receptors involved in the innate and adaptive immune
response, costimulatory molecules, and endogenous signaling or tran-
scriptional factors. A number of chemokines [CCL2, CCL3, CLL4, CCL8,
CCL13, CCL19, chemokine (C-X-C motif) ligand (CXCL) 1, CXCL6,
CXCL16] were upregulated in sensitized dogs after allergen chal-
lenge, similar to what is observed in human atopic dermatitis (Taha
et al. 2000; Giustizieri et al. 2001; Kaburagi et al. 2001). Similarly, the
cytokine IL-33 was upregulated in our study and was also shown to
play a role in human atopic dermatitis and anaphylaxis (Prefontaine
et al. 2009). More details regarding the genes related to inflammation
are discussed in the File S1.
DEG related to skin barrier function
There is increasing evidence that a defective skin barrier plays an
essential role in AD in humans and dogs, although it is not clear in
dogs if this defect is primary or secondary. In some humans with AD,
genetic mutations lead to a defective skin barrier function and (in
combination with environmental factors) to an increased penetration
of allergens, resulting in sensitization and development of atopic
disease (Elias and Schmuth 2009). Defects of the skin barrier have also
been reported in cAD (Inman et al. 2001; Hightower et al. 2008;
Marsella et al. 2008). The epidermis serves as a barrier between the
body and the environment. Its outermost layer, the stratum corneum,
is multilayered and composed of flattened, non-nucleated corneocytes
surrounded by a cornified envelope (CE) and multiple planar lamellar
sheets and is enriched in ceramides, cholesterol, and free fatty acids
(Elias 2005). Normal development of the CE plays a central role for
the functions of the stratum corneum (Credille et al. 2009). For the
physiological properties of the skin, a balance between normal cell
proliferation and differentiation and controlled cell desquamation by
corneosome degradation are essential (Chapman and Walsh 1990).
Filaggrin proteins are essential for the formation of a cornified enve-
lope, and a loss-of-function mutation has been described in humans
with atopic dermatitis (Palmer et al. 2006). In contrast, in our study,
not filaggrin, but rather filaggrin2, a protein with a possible overlap-
ping and synergistic role with filaggrin, was decreased in the allergen-
exposed skin of sensitized dogs. There is controversial evidence for the
role of filaggrin2 in human atopic dermatitis (Wu et al. 2009; Broccardo
et al. 2011; Marenholz et al. 2011). In addition, skin-specific aspartic
peptidase retroviral-like 1 (ASPRV1), a protein important for post-
translational processing of profilaggrin to filaggrin (Matsui et al.
2011), was downregulated in sensitized dogs after allergen treatment,
in contrast to control dogs. Precursors for proteins important for the
cornified envelope and enzymes important for crosslinking of such
proteins were both downregulated in our sensitized dogs, further
n Table 3 Gene set 1 and set 2 results of DAVID analysis with the highest enrichment scores
Gene Set Functional Annotation Cluster Descriptiona Enrichm. Scoreb Genesc
1 Immune response (49; 4.73)d; inflammatory response (31; 6-36); response to wounding
(37; 4.65); defense response (39; 4.23)
15.29 65
2 Epidermis development (13, 8.53); epidermal cell differentiation (7; 11.74); epithelial cell
differentiation (8; 7.05); keratinocyte differentiation (6, 10.98), epithelium development
(9;0.4.79); cornified envelope (3; 16.60); keratinization (3; 8.43)
4.14 14
2 Cytoskeleton (27; 2.38) 3.23 27
2 Cell junction (16; 3.76); anchoring junction (9; 6.37); apical junction complex (6; 7.38);
adherens junction (7; 5.50)
2.22 16
2 Desmosome (3; 18.26), tight junction (3; 5.84) 1.58 6
a
Based on the most prominent "terms."
b
Geometric mean (in 2log10) of p-values of groups with corresponding "annotation clusters."
c
Total number of genes in one cluster.
d
In parentheses: number of genes and the "fold enrichment of the functional term."
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implying a role for a postinflammatory change of the epidermal
barrier. For the mechanical stability of the skin, intercellular con-
nections such as desmosomes are important. A number of molecules
relevant for intercellular adhesions, such as desmoplakin (DSP),
desmoglein 1 (DSG1), and tight junction proteins such as occludin
(OCLN) participate in the keratinocyte adhesion (Broccardo et al.
2011; Ando-Akatsuka et al. 1996). DSP, DSG1, and OCLN expres-
sion was reduced in allergen PT skin of sensitized dogs. Proteases
are involved in the process of corneocyte desquamation (Horikoshi
et al. 1999) and activate or inactivate antimicrobial peptides such as
cathelicidines in the skin (Yamasaki et al. 2006). Genes encoding for
protease inhibitors such as the gene "serine peptidase inhibitor,
Kazal type 5" (SPINK5) are important to prevent excessive protease
activity resulting in skin barrier defects (Hansson et al. 2002;
Denecker et al. 2008), and polymorphisms in this gene have been
shown to be associated with human AD (Walley et al. 2001; Nishio
et al. 2003; Weidinger et al. 2008). The sensitized dogs in our study
showed reduced expression of SPINK5 24 hr after allergen PT. All
those changes point to a defect barrier as a consequence of allergic
inflammation in the dogs studied. More details regarding the genes
related to the epidermal barrier function are discussed in File S1.
CONCLUSION
Our results show that these sensitized dogs developed changes in gene
expression related to a defective skin barrier after allergen PT similar
to those reported in humans and dogs suffering from naturally
occurring AD. Skin inflammation induced by the allergen patch test
after 24 hr resulted in changes at the molecular level, which can lead to
impaired keratinocyte differentiation and an abnormal development
of the cornified envelope. Additionally, the skin barrier was disrupted
due to mechanical trauma (scratching). Mechanisms leading to
a decreased expression of genes essential for skin barrier formation
are largely unknown. In many cases of cAD, clinical signs are probably
associated with a combination of several differentially expressed genes
rather than one single gene defect. The reduced expression of genes
associated with inflammation observed in the control dogs could be
due to a negative feedback mechanism, which the sensitized dogs lack.
Consequently, in our sensitized dogs, the allergen-induced cutaneous
inflammation leads to skin barrier dysfunctions that were induced by
sensitization. Furthermore, new genes potentially involved in the
pathophysiology of cAD and possible new targets for therapeutic
interventions in cAD were identified.
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